DANIEL WILLIAMSON: Open Payments
NPI 1396192407 · WATERTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 63 payments from 13 companies in 2025. Trend: 2023 $908 · 2024 $739 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $267 |
| E.R. Squibb & Sons, L.L.C. | 14 | $226 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| ABBVIE INC. | 6 | $106 |
| Alkermes, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| Supernus Pharmaceuticals, Inc. | 5 | $95 |
| Biogen, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: CAPLYTA, COBENFY, REXULTI, VRAYLAR, ARISTADA, Qelbree, UZEDY, ZURZUVAE.
Industry payments across NY — which companies pay providers there.
